Literature DB >> 4676274

Effects of clozapine on cerebral catecholaminergic neurone systems.

G Bartholini, W Haefely, M Jalfre, H H Keller, A Pletscher.   

Abstract

1. Clozapine, a dibenzodiazepine derivative claimed to possess antipsychotic properties in man without producing extrapyramidal disorders, greatly increased the turnover of cerebral dopamine in the rat.2. The drug itself was virtually devoid of cataleptigenic activity in rats; however, it antagonized prochlorperazine-induced catalepsy.3. It is proposed that clozapine causes a blockade of striatal dopamine receptors which is of the surmountable type in contrast to that produced by cataleptigenic neuroleptics. In addition, clozapine may also increase the turnover of cerebral noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4676274      PMCID: PMC1666362          DOI: 10.1111/j.1476-5381.1972.tb06898.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  Sinistrotorsion in guinea pigs as a method of screening central anticholinergic activity.

Authors:  M de JONGE; A B FUNCKE
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-06-01

3.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

4.  The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse.

Authors:  G F Murphy; D Robinson; D F Sharman
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

5.  Effect of drugs used in psychoses on cerebral dopamine metabolism.

Authors:  R O'Keeffe; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

6.  The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine).

Authors:  G Stille; H Lauener; E Eichenberger
Journal:  Farmaco Prat       Date:  1971-10
  6 in total
  28 in total

1.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Behavioural characterization of neuroleptic properties in the rodent.

Authors:  B Costall; R J Naylor
Journal:  Proc R Soc Med       Date:  1977

3.  A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period.

Authors:  L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Multiple neurochemical action of clozapine: a quantitative autoradiographic study of DA2, opiate and benzodiazepine receptors in the rat brain after long-term treatment.

Authors:  L Giardino; L Calzà; P V Piazza; G Amato
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.

Authors:  R J Stawarz; H Hill; S E Robinson; P Setler; J V Dingell; F Sulser
Journal:  Psychopharmacologia       Date:  1975-08-21

Review 6.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

7.  On the mechanism of action of clozapine on the adrenergic neurone.

Authors:  R L Dorris; P A Shore
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

8.  Clinical pharmacokinetics of clozapine in chronic schizophrenic patients.

Authors:  Y F Cheng; T Lundberg; U Bondesson; L Lindström; J Gabrielsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Inhibition of 4,alpha-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chloropromazine, haloperidol, clozapine and thioridazine.

Authors:  J Buus Lassen
Journal:  Psychopharmacologia       Date:  1975-07-23

Review 10.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.